4502.T

Takeda Pharmaceutical Co. Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$51.98B

PE Ratio

72.52

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$28.29B

Net Income (TTM)

$716.6M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

4.00%

Profit Margin

3.00%

Return on Equity

—

Debt to Equity Ratio

0.64

Dividend Yield

4.00%

All fundamentals

Core6 fields›

Market Cap$51.98B

Revenue TTM$28.29B

Shares Outstanding1.58B

Float1507534858

Insider Ownership0.00%

Institutional Ownership49.00%

Growth Estimates9 fields›

Revenue Growth (Quarterly YoY)4.00%

Rev Growth Est 1Y Forward0.01

EPS Growth (Quarterly YoY)330.00%

EPS Growth Est Quarterly43.14

LT EPS Growth Estimates43.00%

EBITDA Growth (Quarterly YoY)81.00%

CFO Growth (Quarterly YoY)-1.00%

FCF Growth (Quarterly YoY)0.00%

Dividend Growth (Quarterly YoY)2.00%

Operations22 fields›

Revenue TTM$28.29B

Gross Margin TTM66.00%

Gross Margin (Quarterly)66.00%

Operating Margin TTM11.00%

Operating Margin (Quarterly)14.00%

Operating Expenses TTM$2.31B

Profit Margin TTM3.00%

Profit Margin (Quarterly)9.00%

Net Income TTM$716.6M

EPS TTM70.73

EPS (Quarterly)65.67

EBIT Margin TTM27.97%

EBITDA Margin TTM29.00%

EBITDA Margin (Quarterly)38.00%

EBITDA TTM$8.07B

CFO % of Revenue TTM25.00%

CFO % of Revenue (Quarterly)29.00%

CFO TTM$7.11B

Capex % of Revenue TTM4.00%

Capital Expenditures$1.21B

FCF % of Revenue (Quarterly)17.00%

FCF TTM$5.90B

Efficiency1 fields›

ROA2.00%

Valuation12 fields›

P/E (TTM)72.52

P/E Forward10.62

PEG0.33

P/CFO7.31

P/FCF8.81

EV/Revenues (TTM)2.77

Price To Book1.07

Price to Tangible Book-5.04

Earnings Yield1.00%

FCF Yield11.00%

Dividend Yield4.00%

Payout Ratio146.00%

Liquidity13 fields›

Cash Per Share239.9

Current Ratio1.01

Total Debt$9.12T

Goodwill & Intangibles$9268896.00T

Total Assets$97.63B

Total Liabilities$187.26B

Shareholders Equity$48.43B

Debt to Equity0.64

Debt to Assets59.00%

Interest Expense$2.31B

CFO to Debt (TTM)0.12

Debt to EBITDA (TTM)1130.25

Goodwill % of Assets60153365.00%

Yields4 fields›

Dividend Yield4.00%

Payout Ratio146.00%

Earnings Yield1.00%

Buyback Yield-2.00%